House Bill 5133
116th Congress(2019-2020)
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
Introduced
Introduced in House on Nov 18, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5133
Congress
116
Policy Area
Commerce
Commerce
Primary focus of measure is business investment, development, regulation; small business; consumer affairs; competition and restrictive trade practices; manufacturing, distribution, retail; marketing; intellectual property. Measures concerning international competitiveness and restrictions on imports and exports may fall under Foreign Trade and International Finance policy area.
No House votes have been held for this bill.
Summary
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
This bill prohibits, subject to certain exceptions, the practice of product hopping, which is presumed when a drug manufacturer obtains removal of a drug from the Food and Drug Administration's approved drug list, discontinues a drug, or markets a reformulation of an already approved drug during a certain period after which the manufacturer has been notified that a competing drug manufacturer has applied for generic drug approval.
12/24/2020
Placed on the Union Calendar, Calendar No. 578.
12/24/2020
Reported by the Committee on Judiciary. H. Rept. 116-695.
11/21/2019
Ordered to be Reported.
11/21/2019
Committee Consideration and Mark-up Session Held.
11/19/2019
Subcommittee on Antitrust, Commercial, and Administrative Law Discharged.
11/18/2019
Referred to the House Committee on the Judiciary.
11/18/2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
11/18/2019
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:44:05 PM